ID   GATM_RAT                Reviewed;         423 AA.
AC   P50442; Q6ITZ7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   02-OCT-2024, entry version 155.
DE   RecName: Full=Glycine amidinotransferase, mitochondrial;
DE            EC=2.1.4.1 {ECO:0000269|PubMed:6766137};
DE   AltName: Full=L-arginine:glycine amidinotransferase;
DE   AltName: Full=Transamidinase;
DE   Flags: Precursor;
GN   Name=Gatm; Synonyms=Agat;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INDUCTION.
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;
RX   PubMed=8021264; DOI=10.1016/s0021-9258(17)32477-8;
RA   Guthmiller P., van Pilsum J.F., Boen J.R., McGuire D.M.;
RT   "Cloning and sequencing of rat kidney L-arginine:glycine
RT   amidinotransferase. Studies on the mechanism of regulation by growth
RT   hormone and creatine.";
RL   J. Biol. Chem. 269:17556-17560(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 51-64.
RX   PubMed=3057136; DOI=10.1093/jn/118.11.1403;
RA   Gross M.D., Simon A.M., Jenny R.J., Gray E.D., McGuire D.M.,
RA   van Pilsum J.F.;
RT   "Multiple forms of rat kidney L-arginine:glycine amidinotransferase.";
RL   J. Nutr. 118:1403-1409(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 120-358.
RA   Zink R.M., Westberg M.C., Van Pilsum J.F.;
RT   "The comparative cDNA sequences of some mammalian kidney L-arginine:glycine
RT   amidinotransferase genes and their evolutionary significance.";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   PROTEIN SEQUENCE OF 244-260, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Spinal cord;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (NOV-2006) to UniProtKB.
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND INDUCTION.
RX   PubMed=6766137; DOI=10.1016/s0021-9258(19)86155-0;
RA   McGuire D.M., Tormanen C.D., Segal I.S., Van Pilsum J.F.;
RT   "The effect of growth hormone and thyroxine on the amount of L-
RT   arginine:glycine amidinotransferase in kidneys of hypophysectomized rats.
RT   Purification and some properties of rat kidney transamidinase.";
RL   J. Biol. Chem. 255:1152-1159(1980).
RN   [7]
RP   INDUCTION.
RX   PubMed=6384218; DOI=10.1016/s0021-9258(20)71316-5;
RA   McGuire D.M., Gross M.D., Van Pilsum J.F., Towle H.C.;
RT   "Repression of rat kidney L-arginine:glycine amidinotransferase synthesis
RT   by creatine at a pretranslational level.";
RL   J. Biol. Chem. 259:12034-12038(1984).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=3512696; DOI=10.1177/34.4.3512696;
RA   McGuire D.M., Gross M.D., Elde R.P., van Pilsum J.F.;
RT   "Localization of L-arginine-glycine amidinotransferase protein in rat
RT   tissues by immunofluorescence microscopy.";
RL   J. Histochem. Cytochem. 34:429-435(1986).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=8035648; DOI=10.1016/0024-3205(94)00645-8;
RA   Watanabe Y., Van Pilsum J.F., Yokoi I., Mori A.;
RT   "Synthesis of neuroactive guanidino compounds by rat kidney L-arginine:
RT   glycine amidinotransferase.";
RL   Life Sci. 55:351-358(1994).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   PubMed=9623603; DOI=10.1095/biolreprod58.6.1437;
RA   Lee H., Kim J.H., Chae Y.J., Ogawa H., Lee M.H., Gerton G.L.;
RT   "Creatine synthesis and transport systems in the male rat reproductive
RT   tract.";
RL   Biol. Reprod. 58:1437-1444(1998).
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=11165387; DOI=10.1016/s0169-328x(00)00269-2;
RA   Braissant O., Henry H., Loup M., Eilers B., Bachmann C.;
RT   "Endogenous synthesis and transport of creatine in the rat brain: an in
RT   situ hybridization study.";
RL   Brain Res. Mol. Brain Res. 86:193-201(2001).
RN   [12]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=15918910; DOI=10.1186/1471-213x-5-9;
RA   Braissant O., Henry H., Villard A.M., Speer O., Wallimann T., Bachmann C.;
RT   "Creatine synthesis and transport during rat embryogenesis: spatiotemporal
RT   expression of AGAT, GAMT and CT1.";
RL   BMC Dev. Biol. 5:9-9(2005).
RN   [13]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=19826191;
RA   Garcia-Miranda P., Garcia-Delgado M., Peral M.J., Calonge M.L.,
RA   Ilundain A.A.;
RT   "Ontogeny regulates creatine metabolism in rat small and large intestine.";
RL   J. Physiol. Pharmacol. 60:127-133(2009).
CC   -!- FUNCTION: Transamidinase that catalyzes the transfer of the amidino
CC       group of L-arginine onto the amino moiety of acceptor metabolites such
CC       as glycine, beta-alanine, gamma-aminobutyric acid (GABA) and taurine
CC       yielding the corresponding guanidine derivatives (PubMed:6766137,
CC       PubMed:8035648). Catalyzes the rate-limiting step of creatine
CC       biosynthesis, namely the transfer of the amidino group from L-arginine
CC       to glycine to generate guanidinoacetate, which is then methylated by
CC       GAMT to form creatine (By similarity). Provides creatine as a source
CC       for ATP generation in tissues with high energy demands, in particular
CC       skeletal muscle, heart and brain (PubMed:6766137).
CC       {ECO:0000250|UniProtKB:P50440, ECO:0000269|PubMed:6766137,
CC       ECO:0000305|PubMed:8035648}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycine + L-arginine = guanidinoacetate + L-ornithine;
CC         Xref=Rhea:RHEA:13201, ChEBI:CHEBI:32682, ChEBI:CHEBI:46911,
CC         ChEBI:CHEBI:57305, ChEBI:CHEBI:57742; EC=2.1.4.1;
CC         Evidence={ECO:0000269|PubMed:6766137};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:13202;
CC         Evidence={ECO:0000305|PubMed:6766137};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-aminobutanoate + L-arginine = 4-guanidinobutanoate + L-
CC         ornithine; Xref=Rhea:RHEA:75939, ChEBI:CHEBI:32682,
CC         ChEBI:CHEBI:46911, ChEBI:CHEBI:57486, ChEBI:CHEBI:59888;
CC         Evidence={ECO:0000305|PubMed:8035648};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75940;
CC         Evidence={ECO:0000305|PubMed:8035648};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=beta-alanine + L-arginine = 3-guanidinopropanoate + L-
CC         ornithine; Xref=Rhea:RHEA:75943, ChEBI:CHEBI:32682,
CC         ChEBI:CHEBI:46911, ChEBI:CHEBI:57593, ChEBI:CHEBI:57966;
CC         Evidence={ECO:0000250|UniProtKB:P50440};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75944;
CC         Evidence={ECO:0000250|UniProtKB:P50440};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-arginine + taurine = L-ornithine + taurocyamine;
CC         Xref=Rhea:RHEA:75947, ChEBI:CHEBI:32682, ChEBI:CHEBI:46911,
CC         ChEBI:CHEBI:58064, ChEBI:CHEBI:507393;
CC         Evidence={ECO:0000250|UniProtKB:P50440};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75948;
CC         Evidence={ECO:0000305|PubMed:6766137};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.8 mM for arginine (alpha-transamidinase form)
CC         {ECO:0000269|PubMed:6766137};
CC         KM=2.4 mM for arginine (beta-transamidinase form)
CC         {ECO:0000269|PubMed:6766137};
CC         KM=3.0 mM for glycine (alpha-transamidinase form)
CC         {ECO:0000269|PubMed:6766137};
CC         KM=3.1 mM for glycine (beta-transamidinase form)
CC         {ECO:0000269|PubMed:6766137};
CC         KM=27.2 mM for 4-aminobutanoate (alpha-transamidinase form)
CC         {ECO:0000269|PubMed:8035648};
CC         KM=24.9 mM for 4-aminobutanoate (beta-transamidinase form)
CC         {ECO:0000269|PubMed:8035648};
CC         KM=23.0 mM for lysine (alpha-transamidinase form)
CC         {ECO:0000269|PubMed:8035648};
CC         KM=23.5 mM for lysine (beta-transamidinase form)
CC         {ECO:0000269|PubMed:8035648};
CC         KM=23.9 mM for 5-amino-valerate (alpha-transamidinase form)
CC         {ECO:0000269|PubMed:8035648};
CC         KM=23.5 mM for 5-amino-valerate (beta-transamidinase form)
CC         {ECO:0000269|PubMed:8035648};
CC         KM=57.4 mM for 3-aminopropanoate (alpha-transamidinase form)
CC         {ECO:0000269|PubMed:8035648};
CC         KM=57.5 mM for 3-aminopropanoate (beta-transamidinase form)
CC         {ECO:0000269|PubMed:8035648};
CC         KM=174 mM for ethanolamine (alpha-transamidinase form)
CC         {ECO:0000269|PubMed:8035648};
CC         KM=171 mM for ethanolamine (beta-transamidinase form)
CC         {ECO:0000269|PubMed:8035648};
CC         KM=392 mM for taurine (alpha-transamidinase form)
CC         {ECO:0000269|PubMed:8035648};
CC         KM=450 mM for taurine (beta-transamidinase form)
CC         {ECO:0000269|PubMed:8035648};
CC         Vmax=0.39 umol/min/mg enzyme with L-arginine and glycine as
CC         substrates (alpha-transamidinase form) {ECO:0000269|PubMed:6766137};
CC         Vmax=0.37 umol/min/mg enzyme with L-arginine and glycine as
CC         substrates (beta-transamidinase form) {ECO:0000269|PubMed:6766137};
CC         Vmax=39.8 umol/h/mg enzyme with L-arginine and glycine as substrates
CC         (alpha-transamidinase form) {ECO:0000269|PubMed:8035648};
CC         Vmax=27.0 umol/h/mg enzyme with L-arginine and glycine as substrates
CC         (beta-transamidinase form) {ECO:0000269|PubMed:8035648};
CC         Vmax=16.8 umol/h/mg enzyme with L-arginine and 4-aminobutanoate as
CC         substrates (alpha-transamidinase form) {ECO:0000269|PubMed:8035648};
CC         Vmax=11.8 umol/h/mg enzyme with L-arginine and 4-aminobutanoate as
CC         substrates (beta-transamidinase form) {ECO:0000269|PubMed:8035648};
CC         Vmax=12.0 umol/h/ug enzyme with L-arginine and lysine as substrates
CC         (alpha-transamidinase form) {ECO:0000269|PubMed:8035648};
CC         Vmax=10.1 umol/h/ug enzyme with L-arginine and lysine as substrates
CC         (beta-transamidinase form) {ECO:0000269|PubMed:8035648};
CC         Vmax=13.9 umol/h/ug enzyme with L-arginine and 5-amino-valerate as
CC         substrates (alpha-transamidinase form) {ECO:0000269|PubMed:8035648};
CC         Vmax=9.7 umol/h/ug enzyme with L-arginine and 5-amino-valerate as
CC         substrates (beta-transamidinase form) {ECO:0000269|PubMed:8035648};
CC         Vmax=10.8 umol/h/ug enzyme with L-arginine and 3-aminopropanoate as
CC         substrates (alpha-transamidinase form) {ECO:0000269|PubMed:8035648};
CC         Vmax=7.7 umol/h/ug enzyme with L-arginine and 3-aminopropanoate as
CC         substrates (beta-transamidinase form) {ECO:0000269|PubMed:8035648};
CC         Vmax=12.4 umol/h/ug enzyme with L-arginine and ethanolamine as
CC         substrates (alpha-transamidinase form) {ECO:0000269|PubMed:8035648};
CC         Vmax=9.4 umol/h/ug enzyme with L-arginine and ethanolamine as
CC         substrates (beta-transamidinase form) {ECO:0000269|PubMed:8035648};
CC         Vmax=2.8 umol/h/ug enzyme with L-arginine and taurine as substrates
CC         (alpha-transamidinase form) {ECO:0000269|PubMed:8035648};
CC         Vmax=2.1 umol/h/ug enzyme with L-arginine and taurine as substrates
CC         (beta-transamidinase form) {ECO:0000269|PubMed:8035648};
CC         Note=Two forms of the enzyme (denoted alpha and beta) with slightly
CC         different kinetic properties are present in cellular extracts. The
CC         molecular basis of the differences is unclear.;
CC   -!- PATHWAY: Amine and polyamine biosynthesis; creatine biosynthesis;
CC       creatine from L-arginine and glycine: step 1/2.
CC       {ECO:0000305|PubMed:6766137}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:P50440}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in the kidney and pancreas,
CC       especially in the proximal tubules of the kidney, and alpha cells of
CC       the pancreatic islets (at protein level). Moderately expressed in liver
CC       hepatocytes (at protein level). Expressed in the kidney, pancreas,
CC       liver, colon, ileum, jejunum, heart and skeletal muscle. In
CC       reproductive tissues, expressed in the testis, epididymis, ovary,
CC       oviduct and uterus. Expressed throughout the brain in neurons,
CC       astrocytes and oligodendrocytes. In 12.5 dpc embryos, it is expressed
CC       in the middle part of the somites, hepatic primordium and wall of the
CC       dorsal aorta. Expressed in 15.5 dpc embryos in isolated cells
CC       throughout the central nervous system, skeletal muscles, gonad
CC       primordia, caudal somites, liver and pancreas, but not in the choroid
CC       plexus, root ganglia or kidney. Expressed in skeletal muscle, kidney,
CC       pancreas, central nervous system, liver and intestine epithelial cells,
CC       but not in epidermis, dermis, olfactory epithelium, trachea, lung,
CC       stomach or heart in 18.5 dpc embryos. {ECO:0000269|PubMed:11165387,
CC       ECO:0000269|PubMed:15918910, ECO:0000269|PubMed:19826191,
CC       ECO:0000269|PubMed:3512696, ECO:0000269|PubMed:9623603}.
CC   -!- DEVELOPMENTAL STAGE: Expressed throughout embryogenesis. Expression in
CC       the colon and small intestine is highest in newborns and declines with
CC       age. Expression in the kidney increases with age.
CC       {ECO:0000269|PubMed:15918910, ECO:0000269|PubMed:19826191}.
CC   -!- INDUCTION: Expression is induced by growth hormone and repressed by
CC       dietary intake of creatine. {ECO:0000269|PubMed:6384218,
CC       ECO:0000269|PubMed:6766137, ECO:0000269|PubMed:8021264}.
CC   -!- SIMILARITY: Belongs to the amidinotransferase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U07971; AAA21250.1; -; mRNA.
DR   EMBL; BC081785; AAH81785.1; -; mRNA.
DR   EMBL; AY625271; AAT39897.1; -; mRNA.
DR   PIR; A54140; A54140.
DR   RefSeq; NP_112293.1; NM_031031.2.
DR   AlphaFoldDB; P50442; -.
DR   SMR; P50442; -.
DR   STRING; 10116.ENSRNOP00000000181; -.
DR   BindingDB; P50442; -.
DR   iPTMnet; P50442; -.
DR   PhosphoSitePlus; P50442; -.
DR   jPOST; P50442; -.
DR   PaxDb; 10116-ENSRNOP00000000181; -.
DR   GeneID; 81660; -.
DR   KEGG; rno:81660; -.
DR   UCSC; RGD:71090; rat.
DR   AGR; RGD:71090; -.
DR   CTD; 2628; -.
DR   RGD; 71090; Gatm.
DR   eggNOG; ENOG502QVCA; Eukaryota.
DR   HOGENOM; CLU_047415_1_0_1; -.
DR   InParanoid; P50442; -.
DR   OrthoDB; 2347075at2759; -.
DR   PhylomeDB; P50442; -.
DR   BioCyc; MetaCyc:MONOMER-7583; -.
DR   BRENDA; 2.1.4.1; 5301.
DR   Reactome; R-RNO-71288; Creatine metabolism.
DR   UniPathway; UPA00104; UER00579.
DR   PRO; PR:P50442; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005829; C:cytosol; IDA:RGD.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:RGD.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; ISO:RGD.
DR   GO; GO:0005739; C:mitochondrion; IDA:RGD.
DR   GO; GO:0015067; F:amidinotransferase activity; IDA:RGD.
DR   GO; GO:0015068; F:glycine amidinotransferase activity; IDA:RGD.
DR   GO; GO:0006601; P:creatine biosynthetic process; ISO:RGD.
DR   GO; GO:0006600; P:creatine metabolic process; ISO:RGD.
DR   GO; GO:1990402; P:embryonic liver development; IEP:RGD.
DR   GO; GO:0001822; P:kidney development; IDA:RGD.
DR   GO; GO:0007611; P:learning or memory; ISO:RGD.
DR   GO; GO:0014889; P:muscle atrophy; ISO:RGD.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0046689; P:response to mercury ion; IDA:RGD.
DR   GO; GO:0007584; P:response to nutrient; IDA:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; IEP:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IDA:RGD.
DR   GO; GO:0042246; P:tissue regeneration; IEP:RGD.
DR   CDD; cd21136; amidinotransferase_AGAT-like; 1.
DR   InterPro; IPR033195; AmidinoTrfase.
DR   PANTHER; PTHR10488; GLYCINE AMIDINOTRANSFERASE, MITOCHONDRIAL; 1.
DR   PANTHER; PTHR10488:SF1; GLYCINE AMIDINOTRANSFERASE, MITOCHONDRIAL; 1.
DR   SUPFAM; SSF55909; Pentein; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Direct protein sequencing; Membrane; Mitochondrion;
KW   Mitochondrion inner membrane; Phosphoprotein; Reference proteome;
KW   Transferase; Transit peptide.
FT   TRANSIT         1..43
FT                   /note="Mitochondrion"
FT   CHAIN           44..423
FT                   /note="Glycine amidinotransferase, mitochondrial"
FT                   /id="PRO_0000001208"
FT   ACT_SITE        254
FT                   /evidence="ECO:0000250|UniProtKB:P50440"
FT   ACT_SITE        303
FT                   /evidence="ECO:0000250|UniProtKB:P50440"
FT   ACT_SITE        407
FT                   /note="Amidino-cysteine intermediate"
FT                   /evidence="ECO:0000250|UniProtKB:P50440"
FT   BINDING         170
FT                   /ligand="arginine"
FT                   /ligand_id="ChEBI:CHEBI:32696"
FT                   /evidence="ECO:0000250|UniProtKB:P50440"
FT   BINDING         305
FT                   /ligand="arginine"
FT                   /ligand_id="ChEBI:CHEBI:32696"
FT                   /evidence="ECO:0000250|UniProtKB:P50440"
FT   BINDING         322
FT                   /ligand="arginine"
FT                   /ligand_id="ChEBI:CHEBI:32696"
FT                   /evidence="ECO:0000250|UniProtKB:P50440"
FT   BINDING         354
FT                   /ligand="arginine"
FT                   /ligand_id="ChEBI:CHEBI:32696"
FT                   /evidence="ECO:0000250|UniProtKB:P50440"
FT   BINDING         355
FT                   /ligand="arginine"
FT                   /ligand_id="ChEBI:CHEBI:32696"
FT                   /evidence="ECO:0000250|UniProtKB:P50440"
FT   MOD_RES         46
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P50440"
FT   MOD_RES         49
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P50440"
FT   MOD_RES         385
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P50440"
SQ   SEQUENCE   423 AA;  48242 MW;  442D7FBA4984DEA0 CRC64;
     MLRVRCLRGG SRGAEAVHYI GSRLGGSLTG WVQRTFQSTQ AATASSQNSC AAEDKATHPL
     PKDCPVSSYN EWDPLEEVIV GRAENACVPP FTVEVKANTY EKYWPFYQKN GGLYFPKDHL
     KKAVAEVEEM CNILSMEGVT VKRPDPIDWS LKYKTPDFES TGLYSAMPRD ILMVVGNEII
     EAPMAWRSRF FEYRAYRSII KDYFHRGAKW TTAPKPTMAD ELYDQDYPIH SVEDRHKLAA
     QGKFVTTEFE PCFDAADFIR AGRDIFAQRS QVTNYLGIEW MRRHLAPDYR VHIISFKDPN
     PMHIDATFNI IGPGLVLSNP DRPCHQIDLF KKAGWTIVTP PTPVIPDDHP LWMSSKWLSM
     NVLMLDEKRV MVDANEVPIQ KMFEKLGIST IKVNIRNANS LGGGFHCWTC DVRRRGTLQS
     YFD
//
